';
Authors Posts by Jason Snyder

Jason Snyder

264 POSTS 0 COMMENTS

RCPA has formalized its opposition to SB 716 in a brief position paper. Senator Laughlin’s SB 716 would amend Pennsylvania’s Mental Health Procedures Act (MHPA) by defining substance use disorder (SUD) as a mental illness, thereby subjecting those with an SUD to the same procedures outlined in MHPA, including an involuntary commitment to a 120-hour hold in a psychiatric hospital, which is commonly referred to as a 302 (Section 302 of MHPA).

RCPA determined its position after months of discussion and analysis, including:

  • Written input from the entire RCPA SUD treatment provider membership;
  • Extensive conversations and meetings with RCPA members, including SUD and mental health treatment providers, the SUD Steering Committee, and governmental entities;
  • Multiple meetings with staff from key legislators’ offices, including Sen. Laughlin;
  • Multiple meetings with the Shapiro administration; and
  • A review of published research detailing experiences other states have had with involuntary commitment for SUD.

RCPA has offered to work with the legislature and Sen. Laughlin to implement alternative strategies that are proven effective in reducing overdoses and connecting those with SUD to treatment.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) will host its Annual Women and Children’s Meeting from 10:00 am – 12:00 pm on Wednesday, December 10. The virtual meeting provides an opportunity to connect, collaborate, and share updates on programs and initiatives that support women and children across the Commonwealth. Participants will hear from county administrators and receive statewide updates highlighting innovative efforts and best practices related to supports and services for women and children in Pennsylvania.

Use the information below to join the meeting or add the meeting to your calendar.

Join the meeting
Meeting ID: 251 287 171 369 74
Passcode: RJ2pc2fR

Dial in by phone
+1 267-332-8737,,471562118# (United States, Philadelphia)
Find a local number
Phone conference ID: 471 562 118#

0 697
Harrisburg, USA - May 24, 2017: Pennsylvania capitol interior dome colorful ceiling in city with American Flags

The planned protest of the state budget impasse for Tuesday, November 18, on the Capitol steps has been cancelled, as Governor Josh Shapiro and members of the General Assembly have agreed to a $50.1 billion budget for the 2025/26 Fiscal Year. This is $2.3 billion more than last year’s budget but less than the Governor’s $51.5 billion proposed budget.

0 1184

A large stakeholder advocacy group is planning to protest the state budget impasse at 12:00 pm on Tuesday, November 18, on the Capitol steps in Harrisburg. Although the group was originally convened to focus on behavioral health, they are encouraging all groups impacted by the impasse to join, as it continues to affect people, programs, and organizations far beyond behavioral health.

As someone with a vested interest in passing the budget, you are encouraged to attend the protest, share this invitation widely, and rally your networks and anyone affected by this issue.

Contact Kathy Quick, Executive Director of the Pennsylvania Mental Health Consumers Association, for more information. If the budget passes before November 18, the event will be canceled.

Photo by Chris Montgomery on Unsplash

Drexel University’s Division of Behavioral Healthcare Education has announced its 33rd Forensic Rights and Treatment Conference to held virtually on Wednesday and Thursday, December 10–11, 2025. The conference theme is “Contemporary Issues Impacting Forensic Services.” The conference will feature live and pre-recorded presentations addressing a wide variety of forensic topics pertinent to behavioral health. The virtual format allows participants to earn additional continuing education credits by accessing session recordings after the conference. More information is available online or by downloading the conference flyer.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) Emerging Drug Trends Symposium, originally scheduled for Tuesday, November 18, has been postponed. The event will now take place on Tuesday, March 31, 2026.

All individuals who previously registered have been automatically re-enrolled for the new date. Those unable to attend on the new date are asked to cancel their registration in DDAP’s Training Management System to allow others to register.

0 471

By Jason Snyder, Director, SUD Treatment Services, BH Division and
Chris McKenzie, Community Relations Coordinator, Pinnacle Treatment Centers
October 15, 2025

Editor’s note: I asked my good friend Chris McKenzie, Community Relations Coordinator at Pinnacle Treatment Centers, to collaborate with me on a blog about what we both see as a gap between what research tells us about medications to treat opioid use disorder and the prevailing attitudes toward it in the treatment and recovery communities. We have shared our firsthand experiences here as Part I of a two-part blog. In Part II, we will discuss our suggestions for greater genuine acceptance of multiple pathways to recovery as well as address feedback we may get on Part I.


(Jason)

Several years ago, I met an individual in recovery from addiction who eventually went on to become a therapist. As our friendship and my own 12 step-based recovery from substance use disorder evolved, so did my position on medication to treat opioid use disorder (MOUD). His did not. Where once I was staunchly opposed, I was now beginning to embrace the idea, if for no other reason than the rising overdose death toll and the devastating stories of loss I continued to hear. I bought into the messaging that said we can’t treat someone who is dead.

My friend still failed to see the light.

“But the research shows it to be highly effective,” I ineffectively implored.

“Well, you need to show me this research, because I just don’t see it,” he replied.

In the end, it really didn’t matter what research I showed him, because that research did not match his reality. It could not overcome his perception, personal experience with individuals using MOUD, and definition of recovery, which was based on a belief that use of medication was nothing more than substituting one drug for another. And unfortunately, he is not an anomaly, at least within what I’ll call the traditional treatment system and recovery communities. For most of them, the gold standard is not MOUD. It is abstinence combined with a new way of life, despite what many within these very systems will publicly say.

What my friend saw — and what I sometimes see today – were individuals using MOUD who were living chaotic lives of polysubstance use, with no real ability to manage their own lives. This is what many in the lay public, health care and treatment systems, law enforcement, and legislature, to name a few, also see. And some of these groups have great power in influencing broader access to and acceptance of (or, conversely, opposition to) MOUD, including the ability to make laws that can limit it.

I believe it is fair to ask, “How is that recovery?” Actually, it may not be – yet. Often times, it can be a first necessary step on a path toward change. Consider SAMHSA’s definition: a process of change through which individuals improve their health and wellness, live a self-directed life, and strive to reach their full potential. For many, the start of the process can be chaotic. But if we believe in meeting people where they are and helping them along through a process of change, then we shouldn’t be condemning MOUD. In fact, for many, we should be genuinely encouraging it for whatever length of time necessary for the individual. Yet even under that scenario, not every case will be a success, just as it is not in every other medical and clinical discipline.

But many people lack the foresight or open-mindedness to see beyond their own experience and what’s in front of them right now. So, when these very people — families, friends, peer specialists, counselors, nurses, police, and lawmakers — who have had some negative experience with MOUD make blanket, disparaging statements about it, it has a ripple effect, eventually reaching the very people intended to be helped. In turn, it negatively influences their perceptions and willingness to try this way. And I’ve seen this very scenario end in death, when friends who could not stop using illicit opioids refused to use MOUD because of the stigma put upon them by others.

The danger in riding the high horse of judgment, condescension, and condemnation because others don’t recover like you or because others aren’t experiencing a transformation as you believe it should be is that you put their life in grave danger.

Does MOUD save more lives than abstinence? The research says yes.

Does medication transform the lives of those with SUD? In many instances, it absolutely does.

Does the transformed life that doesn’t align with a particular set of values have less worth than the one traditionally held up as an example of “recovery”?

If we truly believe the answer to the last question is “no,” then why do we still discourage or even demonize medication?


(Chris)

Jason raises two important questions: What is recovery and what is a valid way to get there? I would add one more: Why do we continue to place our own values on other people’s recovery? If we take a moment to reflect on how it might feel when someone does that to us, we might see things a little bit differently.

From my own experiences with substance use, I have learned the importance of examining my biases. The gap between research and reality is a clear case of bias. Recovery is not defined by another person, but is a deeply personal journey. That is why SAMSHA’s definition of recovery is purposely broad. Recovery is a process of change and that process can begin with something as small as a shift in mindset or the very first positive step, as defined by the individual. The individuality of recovery is what makes the definition so powerful, and so necessary.

Yet, this understanding is not always reflected in practice. I once interviewed for a job and was asked if I “worked a program.” I shared that I attended SMART Recovery meetings. The interviewer quickly told me that they only practiced one program at that organization, and it wasn’t SMART Recovery. In that moment, it felt as if every other pathway, including my own, was dismissed as invalid. If I, as someone with professional experience, felt those words like a sharp wound to my own recovery, I can only imagine how discouraging it must be for someone who is just beginning their recovery journey.

This narrow view extends to many places like recovery housing, treatment settings, and peer support programs, where certain approaches are upheld while others, like MOUD, are diminished or outright rejected. Research, once again, clearly shows that MOUD saves lives and this pathway, just as any other, is valid. When institutions or individuals impose these narrow definitions, they not only reinforce bias but also close doors for people who might otherwise succeed.

So how do we move closer to true acceptance of multiple pathways to recovery, including the use of medications? In Part II of our blog, we’ll offer our suggestions. In the meantime, if you have any ideas about this or thoughts on the subject or the blog in general, let us know.

Email Jason or Chris with your thoughts, or start a conversation on LinkedIn.

Image by Tom und Nicki Löschner from Pixabay

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) has released its Compulsive and Problem Gambling Annual Report, highlighting prevention and treatment efforts for state fiscal year (SFY) 2024/25.

This year’s report reflects continued progress in connecting Pennsylvanians to help and expanding prevention outreach across the Commonwealth.

Highlights include:

  • Continued growth in texts and online chats to the 1-800-GAMBLER helpline;
  • Increased admissions to problem gambling outpatient treatment programs — up 24 percent from the previous year;
  • Forty-one county drug and alcohol offices engaged in prevention programming — a 21 percent increase from the prior year; and
  • Nearly 820,000 Pennsylvanians reached through prevention programming — a 28 percent increase from the prior year.

Read the full report.

Flag of Pennsylvania state united states of america

Pennsylvania will receive more than $83 million from the Substance Abuse and Mental Health Services Administration (SAMHSA) in State Opioid Response (SOR) grant funding, which provides critical resources to states and Tribal communities to address the overdose crisis through prevention, opioid overdose reversal medications, treatment (including medications for opioid use disorder [MOUD]) and recovery support. On Monday, the U.S. Department of Health and Human Services (HHS), through SAMHSA, announced a total allocation of more than $1.5 billion in Fiscal Year 2025 continuation funding for SOR and Tribal Opioid Response (TOR) grants, with $1.48 billion committed to SOR and nearly $63 million committed to TOR.

This most recent round of funding is the second year of the three-year SOR IV grant cycle, which began October 1, 2024, and runs through September 30, 2027. The Pennsylvania Department of Drug and Alcohol Programs (DDAP) manages and distributes SOR funding, which comprises a significant percentage of DDAP’s annual budget.

Since the SOR program began in 2018, states report that nearly 1.3 million people have received treatment services, including more than 650,000 who received MOUD. Through the SOR program, nearly 1.5 million people have received recovery support services. SAMHSA grantees reported distributing more than 10 million opioid overdose reversal kits, with opioid overdose reversal medications being used to reverse more than 550,000 overdoses. Since the TOR program began in 2018, Tribes report that approximately 16,500 patients have received treatment services, and SAMHSA grantees reported distributing more than 116,500 naloxone kits, with opioid reversal medications being used to reverse more than 1,750 overdoses.

Read SAMHA’s press release.